|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Mar 31, 2022
|
Q3 FY2022
As of Dec 31, 2021
|
Q2 FY2022
As of Sep 30, 2021
|
Q1 FY2022
As of Jun 30, 2021
|
Q3 FY2021
As of Dec 31, 2020
|
Q2 FY2021
As of Sep 30, 2020
|
Q1 FY2021
As of Jun 30, 2020
|
Q4 FY2020
As of Mar 31, 2020
|
Q3 FY2020
As of Dec 31, 2019
|
Q2 FY2020
As of Sep 30, 2019
|
Q1 FY2020
As of Jun 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Bank | ||||||||||||||||||||
| Funds in attorney trust account | ||||||||||||||||||||
| VAT receivable | ||||||||||||||||||||
| Prepaid | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Cash in bank | ||||||||||||||||||||
| Loans receivable | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid stock subscription | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Notes payable, net | ||||||||||||||||||||
| Convertible note payable | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Accrued liabilities, related party | ||||||||||||||||||||
| Advances from related party | ||||||||||||||||||||
| Loans payable, related parties | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and Contingencies | ||||||||||||||||||||
| STOCKHOLDERS' DEFICIT: | ||||||||||||||||||||
| Preferred stock, $0.001 par value. 10,000,000 shares authorized, -0- shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.001 par value, 2,000,000,000 shares authorized, 1,467,475,449 and 1,382,662,949 shares issued and outstanding, respectively | ||||||||||||||||||||
| Treasury stock, 29,015,993 and 0 shares held, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Stock subscription | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total stockholders' deficit attributable to owners of the parent | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total stockholder's deficit | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
Loading...
